HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 9-22-2023 Insider Buy |
Bernd R. Seizinger |
$3.14 CAGR » |
$53,380.00 17,000 shares |
| 9-19-2022 Insider Buy |
Fletcher Payne SR VP & Chief Fin. Officer |
$0.68 CAGR » |
$6,775.00 10,000 shares |
| 9-19-2022 Insider Buy |
William G. Rice Chair, President & CEO |
$0.68 CAGR » |
$6,834.00 10,000 shares |
| 6-6-2022 Insider Buy |
William G. Rice Chair, President & CEO |
$0.97 CAGR » |
$9,681.00 10,000 shares |
| 12-16-2021 Insider Buy |
William G. Rice Chair, President & CEO |
$1.52 CAGR » |
$20,038.16 13,183 shares |
| 12-15-2021 Insider Buy |
Erich Platzer Director |
$1.17 CAGR » |
$316,340.00 270,000 shares |
| 12-15-2021 Insider Buy |
William G. Rice Chair, President & CEO |
$1.12 CAGR » |
$19,960.64 17,822 shares |
| 11-26-2021 Insider Buy |
William G. Rice Chair, President & CEO |
$2.31 CAGR » |
$19,965.33 8,643 shares |
| 11-19-2021 Insider Buy |
Rafael Bejar Sr. VP, Chief Medical Officer |
$2.56 CAGR » |
$25,600.00 10,000 shares |
| 8-5-2021 Insider Buy |
Donald R. Wilson Jr. >10% Owner |
$2.65 CAGR » |
$151,405.75 57,199 shares |
| 4-18-2019 Insider Buy |
William G. Rice Chair, President & CEO |
$1.85 CAGR » |
$18,507.00 10,000 shares |
| 3-19-2019 Insider Buy |
Erich Platzer Director |
$2.19 CAGR » |
$43,805.00 20,000 shares |
| 3-14-2019 Insider Buy |
William G. Rice Chair, President & CEO |
$1.90 CAGR » |
$18,993.00 10,000 shares |
| 3-13-2019 Insider Buy |
Gregory K. Chow Senior VP & CFO |
$1.75 CAGR » |
$26,322.00 15,000 shares |
Also See: Institutional Holders of APTO
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 09/25/2023 | |
| End date: | 05/07/2024 | |
| Start price/share: | $2.97 | |
| End price/share: | $1.23 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -58.59% | |
| Annualized Gain: | -95.04% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $4,141.00 | |
| Years: | 0.62 | |
Aptose Biosciences Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Aptose Biosciences insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding APTO
 Free APTO Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the Aptose Biosciences Insider Buying occurred are:
Planet Labs PBC Insider Buying
|
